Use of Various Doses of S-Ketamine in Treatment of Depression and Pain in Cervical Carcinoma Patients with Mild/Moderate Depression After Laparoscopic Total Hysterectomy
Open accessAbstract
BACKGROUND This study investigated the effects of various doses of S-ketamine on depression and pain management of cervical carcinoma patients with mild/moderate depression. MATERIAL AND METHODS This randomized, double-blind, controlled study included 417 cervical carcinoma patients who received laparoscopic modified radical hysterectomy from April 2015 to July 2018 and who also had mild/moderate depression symptoms based on HAMD-17 scores (8~24). All patients were randomized into 4 groups: 1) the control group, 2) the racemic ketamine group, 3) the high-dose S-ketamine group; and 4) the low-dose S-ketamine group. Pain was assessed using the Visual Analogue Score (VAS), and depression was assessed using theHAMD-17 score. Serum levels of BDNF and 5-HT were measured. RESULTS The 4 groups of patients showed no significant differences in operation time, bleeding volume, hospitalization duration, or complications. The high-dose S-ketamine group showed significantly lower VAS and HAMD-17 scores than all other groups at 1 day and 3 days postoperatively, but no differences were observed in the low-dose S-ketamine group and the racemic ketamine group. The high-dose S-ketamine group showed significantly higher serum BDNF and 5-HT levels at 1 day and 3 days after surgery. However, 1 week after surgery, no difference was observed in any of the treatment groups. CONCLUSIONS At subanesthetic dose, both 0.5 mg/kg and 0.25 mg/kg S-ketamine improved short-term depression and pain for cervical carcinoma patients after surgery, and the effects were better than with the same dose of racemic ketamine.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In Wang et al. (2020), after 5 and 7 days, depression scores were low in all four groups with no significant between-group differences.
“After 5 and 7 days, depression scores were low in all four groups with no significant between-group differences.”
From Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review (2022) · cites this paper as Wang et al., 2020
The Results section, “Comparison of HAMD-17 scores” (page not provided), reports no significant difference among the four groups at day 5. The copy does not establish that depression scores were low at days 5 and 7; its statement that there was no difference at one week appears in the abstract, not in the full-text Results passage on HAMD-17 scores. (LLM, conf=0.82)
Experimental — accuracy not yet measuredIn Wang et al. (2020), depression scores after 1, 2, and 3 days decreased significantly more in all ketamine treatment groups than in the control group.
“Depression scores after 1, 2, and 3 days decreased significantly more in all treatment groups than in the control group.”
From Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review (2022) · cites this paper as Wang et al., 2020
In Wang et al. (2020), the decrease was highest for the high-dose S-ketamine group, with no significant difference between the racemic and low-dose S-ketamine groups.
“This decrease was highest for the high-dose S-ketamine group, while no significant difference was found between the racemic and low-dose S-ketamine groups.”
From Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review (2022) · cites this paper as Wang et al., 2020
Two studies from the same research group found S-ketamine superior to racemic ketamine in treating pain and depression.
“Two studies from the same research group (Liu et al., 2020;Wang et al., 2020) compared racemic and S-ketamine and found S-ketamine to be superior to racemic ketamine in treating pain and depression”
From Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review (2022) · cites this paper as Wang et al., 2020
Esketamine studies on BDNF have been conducted in special populations such as postpartum depression and surgical patients.
“For esketamine, studies have been conducted in special populations, such as patients with postpartum depression [104] or those who have undergone surgery [99,105].”
From Variations in BDNF and Their Role in the Neurotrophic Antidepressant Mechanisms of Ketamine and Esketamine: A Review (2024) · cites this paper as [99]
Ketamine and esketamine were found to increase 5-HT.
“as highlighted in the study by Wang et al., where ketamine and esketamine were indeed found to have an impact on its increase [99].”
From Variations in BDNF and Their Role in the Neurotrophic Antidepressant Mechanisms of Ketamine and Esketamine: A Review (2024) · cites this paper as [99]
In 417 patients with cervical cancer undergoing laparoscopic modified radical hysterectomy, those who received 0.5 mg/kg IV esketamine during surgery had greater increases in BDNF levels in the days following surgery compared to placebo, ketamine, or esketamine 0.25 mg/kg.
“a study of 417 patients with cervical cancer undergoing laparoscopic modified radical hysterectomy found that those who received 0.5 mg/kg intravenous esketamine during surgery had greater increases in BDNF levels in the days following surgery compared to patients treated with placebo, ketamine, or esketamine at a dose of 0.25 mg/kg [99].”
From Variations in BDNF and Their Role in the Neurotrophic Antidepressant Mechanisms of Ketamine and Esketamine: A Review (2024) · cites this paper as [99]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Cervical cancer: A global health crisis
Small, W. C., Bacon, M. A., Bajaj, A., Chuang, L. T., Fisher, B. J., Harkenrider, M. M., Jhingran, A., Kitchener, H. C., Mileshkin, L., Viswanathan, A. N., et al. (2017) · Cancer · doi:10.1002/cncr.30667 · Cited by 1,180 · see citing works
Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
aan het Rot, M., Collins, K. A., Murrough, J. W., Perez, A. M., Reich, D. L., Charney, D. S., & Mathew, S. J. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.038 · Cited by 690 · see citing works
Major depression after breast cancer: a review of epidemiology and treatment
Fann, J. R., Thomas-Rich, A. M., Katon, W. J., Cowley, D., Pepping, M., McGregor, B. A., & Gralow, J. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.10.008 · Cited by 586 · see citing works
Depression and postoperative complications: an overview
Ghoneim, M. M., & O’Hara, M. W. (2016) · BMC Surgery · doi:10.1186/s12893-016-0120-y · Cited by 491 · see citing works
Quantitative MRI of the hippocampus and amygdala in severe depression
Mervaala, E., Föhr, J., Könönen, M., Valkonen‐Korhonen, M., Vainio, P. A., Partanen, K. P. L., Partanen, J. V., Tiihonen, J., Viinamäki, H. T., Karjalainen, A.-M., et al. (2000) · Psychological Medicine · doi:10.1017/s0033291799001567 · Cited by 382 · see citing works
Finocchario‐Kessler, S., Wexler, C., Maloba, M., Mabachi, N. M., Ndikum-Moffor, F. M., & Bukusi, E. A. (2016) · BMC Women s Health · doi:10.1186/s12905-016-0306-6 · Cited by 215 · see citing works
Wang, J., Goffer, Y., Xu, D., Tukey, D. S., Shamir, D. B., Eberle, S. E., Zou, A., Blanck, T. J. J., & Ziff, E. B. (2011) · Anesthesiology · doi:10.1097/aln.0b013e31822f16ae · Cited by 172 · see citing works
Self-citationYang, Y.-L., Liu, L., Wang, Y., Wu, H., Yang, X.-S., Wang, J.-N., & Wang, L. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-393 · Cited by 165 · see citing works
Self-citationYe, Y., Wang, G., Wang, H., & Wang, X. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.07.055 · Cited by 131 · see citing works
Ergun, M., Eyigor, S., Karaca, B., Kisim, A., & Uslu, R. (2013) · European Journal of Cancer Care · doi:10.1111/ecc.12068 · Cited by 127 · see citing works
Psychiatric safety of ketamine in psychopharmacology research
Perry, E. B., Cramer, J. A., Cho, H.-S., Petrakis, I. L., Karper, L. P., Genovese, A., O’Donnell, E., Krystal, J. H., D’Souza, D. C., & Yale Ketamine Study Group (2007) · Psychopharmacology · doi:10.1007/s00213-007-0706-2 · Cited by 117 · see citing works
Yang, Y.-L., Liu, L., Wang, X.-X., Wang, Y., & Wang, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094804 · Cited by 108 · see citing works
Self-citationCervical cancer prevention and treatment in Latin America
Varón, M. L., Baker, E., Maza, M., Fontes‐Cintra, G., López, A., Carvajal, J. M., Nozar, F., Fiol, V., & Schmeler, K. M. (2017) · Journal of Surgical Oncology · doi:10.1002/jso.24544 · Cited by 105 · see citing works
Zuo, D., Lin, L., Liu, Y., Wang, C., Xu, J., Sun, F., Li, L., Li, Z., & Wu, Y. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9611-y · Cited by 99 · see citing works
Paul, R. H., Schaaff, N., Padberg, F., Möller, H., & Frodl, T. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701714370 · Cited by 98 · see citing works
Järventausta, K., Chrapek, W., Kampman, O., Tuohimaa, K., Björkqvist, M., Häkkinen, H., Yli‐Hankala, A., & Leinonen, E. V. J. (2013) · Journal of Ect · doi:10.1097/yct.0b013e318283b7e9 · Cited by 97 · see citing works
Woodhead, C., Cunningham, R., Ashworth, M. J., Barley, E. A., Stewart, R. J., & Henderson, M. J. (2016) · BMC Cancer · doi:10.1186/s12885-016-2842-8 · Cited by 74 · see citing works
Paslakis, G., Gilles, M., Meyer‐Lindenberg, A., & Deuschle, M. (2009) · Pharmacopsychiatry · doi:10.1055/s-0029-1237375 · Cited by 66 · see citing works
Repeated S‐ketamine Infusions in Therapy Resistant Depression: A Case Series
Segmiller, F. M., Rüther, T., Linhardt, A., Padberg, F., Berger, M., Pogarell, O. M., Möller, H., Kohler, C., & Schüle, C. (2013) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.122 · Cited by 65 · see citing works
Cervical Cancer: A Global Health Crisis
Small, W. C., Bacon, M. A., Bajaj, A., Chuang, L. T., Fisher, B. J., Harkenrider, M. M., Jhingran, A., Kitchener, H. C., Mileshkin, L., Viswanathan, A. N., et al. (2017) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000526010.06041.5e · Cited by 54 · see citing works
Larenza, M. P., Knobloch, M., Landoni, M. F., Levionnois, O., Kronen, P., Theurillat, R., Schatzmann, U., & Thormann, W. (2007) · The Veterinary Journal · doi:10.1016/j.tvjl.2007.05.005 · Cited by 38 · see citing works
S-ketamine versus racemic ketamine in dogs: their relative potency as induction agents
Casoni, D. C., Spadavecchia, C., & Adami, C. (2014) · Veterinary Anaesthesia and Analgesia · doi:10.1111/vaa.12200 · Cited by 25 · see citing works
Sun, F., Xiong, Y., Zhou, X.-H., Li, Q., Lu, X., Long, P., Li, L.-J., Cai, M., Wei, Y., Ma, Y., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-4498-4 · Cited by 23 · see citing works
Plasma concentrations of neurotransmitters and postpartum depression.
Xie, R., Xie, H., Krewski, D. R., & He, G. (2018) · PubMed · doi:10.11817/j.issn.1672-7347.2018.03.007 · Cited by 22 · see citing works
Expression levels of resistant genes affect cervical cancer prognosis
Yang, F., Gao, B., Li, R., Li, W., Chen, W., Yu, Z., & Zhang, J. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6328 · Cited by 19 · see citing works
Kaur, M., Agnihotri, M., Das, K., Rai, B., & Ghai, S. (2017) · Asia-Pacific Journal of Oncology Nursing · doi:10.4103/apjon.apjon_56_17 · Cited by 11 · see citing works
Martin‐Jurado, O., Bektas, R. N., Fahrion, A. S., Bettschart‐Wolfensberger, R., & Hammer, S. (2011) · American Journal of Veterinary Research · doi:10.2460/ajvr.72.9.1164 · Cited by 6 · see citing works
Yıldız, Y., Akyol, M., Alacacıoğlu, A., Küçükzeybek, Y., Aşık, N., Taşkaynatan, H., Varol, U., Yıldız, İ., Oflazoğlu, U., Salman, T., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw374.38 · Cited by 5 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Schimmers, N., Breeksema, J. J., Smith-Apeldoorn, S. Y., Veraart, J., van den Brink, W., & Schoevers, R. A. (2022) · Psychopharmacology · doi:10.1007/s00213-021-06027-y · Cited by 162 · see citing works
Luo, T., Deng, Z., Ren, Q., Mu, F., Zhang, Y., & Wang, H. (2024) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2024.111447 · Cited by 75 · see citing works
Antidepressants for the treatment of depression in people with cancer
Vita, G., Compri, B., Matcham, F., Barbui, C., & Ostuzzi, G. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011006.pub4 · Cited by 73 · see citing works
Wang, Y., Zhang, Q., Dai, X., Xiao, G., & Luo, H. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-3343 · Cited by 59 · see citing works
Self-citationZhu, M., Xu, S., Ju, X., Wang, S., & Yu, X. (2022) · Drug Design Development and Therapy · doi:10.2147/dddt.s392784 · Cited by 53 · see citing works
Pardossi, S., Fagiolini, A., & Cuomo, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313098 · Cited by 51 · see citing works
Research advances in the clinical application of esketamine
Zhang, X., Zhang, N., Liu, D., Ding, J., Zhang, Y., & Zhu, Z. (2022) · Ibrain · doi:10.1002/ibra.12019 · Cited by 46 · see citing works
Agnorelli, C., Spriggs, M. J., Godfrey, K., Sawicka, G., Bohl, B., Douglass, H. M., Fagiolini, A. M., Parastoo, H., Carhart-Harris, R. L., Nutt, D. J., et al. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106132 · Cited by 52 · see citing works
Zhang, J., Jia, D., Li, W., Li, X.-H., Ma, Q., & Chen, X.-X. (2023) · BMC Anesthesiology · doi:10.1186/s12871-023-02161-6 · Cited by 41 · see citing works
Gan, S.-L., Long, Y.-Q., Wang, Q., Feng, C.-D., Lai, C.-X., Liu, C., Ding, Y.-Y., Liu, H., Peng, K., & Ji, F. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1128406 · Cited by 37 · see citing works
Recent advances in the study of anesthesia-and analgesia-related mechanisms of S-ketamine
Zhou, J., Peng, G., Liang, W., Chen, Z., Liu, Y., Wang, B., Guo, M., Deng, Y.-L., Jun-ming, Y., Zhong, M., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1228895 · Cited by 39 · see citing works
Zhao, L., Li, Z., Jin, B., Hou, N., & Yang, H. (2024) · BMC Anesthesiology · doi:10.1186/s12871-024-02429-5 · Cited by 37 · see citing works
Wen, Y., Mao, M., Wang, X., Xu, C., Shi, X., Li, P., Tian, Z., Jiang, M., Yuan, H., & Feng, S. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.115765 · Cited by 32 · see citing works
The effect of intravenous ketamine on depressive symptoms after surgery: A systematic review
Wang, J., Sun, Y., Ai, P., Cui, V., Shi, H., An, D., Wu, A., & Wei, C. (2021) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2021.110631 · Cited by 29 · see citing works
Self-citationZhang, Z., Yuan, Z., Zhang, W., Yi-bo, W., Cui, L.-Y., Lu, B.-X., Zhang, J., Gong, J.-F., Qing, J., Cheng, H., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12031152 · Cited by 27 · see citing works
Dhakal, K., Chen, C., Wang, P., Mboineki, J. F., & Adhikari, B. (2024) · BMC Public Health · doi:10.1186/s12889-024-18634-3 · Cited by 24 · see citing works
Hu, Y., Zhang, Q., Qin, G.-C., Zhu, G.-H., Xiang, L., Xu, J.-F., & Gong, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-62824-3 · Cited by 25 · see citing works
Jiang, M., Li, Q., Mao, M., Xu, C., Zhou, R., Wen, Y., Yuan, H., & Feng, S. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.02.127 · Cited by 23 · see citing works
Liu, X., Xiao, Q., & Zhuang, S. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1184709 · Cited by 23 · see citing works
The antidepressant effect and safety of non-intranasal esketamine: A systematic review
Smith-Apeldoorn, S. Y., Vischjager, M., Veraart, J. K. E., Kamphuis, J., Rot, M. A. H., & Schoevers, R. A. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221084055 · Cited by 22 · see citing works
Xing, F., Zhang, T.-T., Yang, Z., Qu, M., Shi, X., Li, Y., Li, Y., Zhang, W., Wang, Z., & Xing, N. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.12.011 · Cited by 20 · see citing works
Wang, H., Te, R., Zhang, J., Su, Y., Zhou, H., Guo, N., Chi, D., & Huang, W. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05753-9 · Cited by 22 · see citing works
Li, C., Cai, Q., Su, Z., Chen, Z., Cao, J., & Xu, F. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1149511 · Cited by 20 · see citing works
Self-citationZhou, S., Liu, Y., Xue, B., & Yuan, P.-G. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114782 · Cited by 18 · see citing works
Wen, Y., Mao, M., Jiang, M., Liu, Q., Li, Q., Wang, X., Yuan, H., Wang, X., & Feng, S. (2024) · International Journal of Surgery · doi:10.1097/js9.0000000000001870 · Cited by 18 · see citing works
Esketamine in depression: putative biomarkers from clinical research
Johnston, J. N., Zarate, C. A., & Kvarta, M. D. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01865-1 · Cited by 18 · see citing works
Lou, X.-J., Qiu, D., Ren, Z.-Y., Hashimoto, K., Zhang, G.-F., & Yang, J. (2024) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2024.103997 · Cited by 17 · see citing works
The efficacy and safety of ketamine for depression in patients with cancer: A systematic review
Azari, L., Hemati, H., Tavasolian, R., Shahdab, S., Tomlinson, S. M., Babilonia, M. B., Huang, J. J., Tometich, D. B., Turner, K. L., Jim, H., et al. (2023) · International Journal of Clinical and Health Psychology · doi:10.1016/j.ijchp.2023.100428 · Cited by 13 · see citing works
Chen, H., Gao, Y., Li, K., An, L., Yan, J., Li, H., & Zhang, J. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v12.i28.6195 · Cited by 12 · see citing works
Efficacy of ketamine for comorbid depression and acute or chronic pain: A systematic review
Balachandran, A., Tassone, V. K., Adamsahib, F., Passa, A.-M. D., Kuburi, S., Demchenko, I., Ladha, K. S., & Bhat, V. (2022) · Frontiers in Pain Research · doi:10.3389/fpain.2022.1022767 · Cited by 13 · see citing works
Gao, W., Li, H., Li, T., Zhang, L., Zhang, T., Lin, W., Wen, Z., Cao, L., & Tan, H. (2023) · Pain and Therapy · doi:10.1007/s40122-023-00533-x · Cited by 11 · see citing works
Sholevar, R., Kromka, W., & Beaussant, Y. (2025) · Journal of Palliative Medicine · doi:10.1089/jpm.2024.0346 · Cited by 12 · see citing works
Esketamine–A quick-acting novel antidepressant without the disadvantages of ketamine
Shoib, S., Kotra, M., Javed, S., Nguyen, V.-S., & Malathesh, B. C. (2022) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2021-0099 · Cited by 11 · see citing works
Li, T., Han, L., Wu, Z., Chen, Y., & Wang, Y. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s513571 · Cited by 12 · see citing works
Self-citationReady for a “breakthrough” with ketamine? A look at recent pharmacological insights!
Himmelseher, S., & Kochs, E. F. (2021) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000001017 · Cited by 10 · see citing works
The Clinician Scientist Training Program in Iran: Catalyzing Clinical Science Advancements
Moghaddan, H. S., & Akhondzadeh, S. (2023) · Avicenna Journal of Medical Biotechnology · doi:10.18502/ajmb.v15i3.12921 · Cited by 10 · see citing works
Ren, L., Yang, J., Li, Y., & Wang, Y. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s457625 · Cited by 9 · see citing works
Self-citationDeng, B.-R., Wang, D., Xie, Z., Wang, Y., Huang, L., Jiang, M., & Shen, T. (2024) · BMC Anesthesiology · doi:10.1186/s12871-024-02430-y · Cited by 8 · see citing works
Self-citationWei, Q., Li, M., Jiang, Y., & Liu, X. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.02.085 · Cited by 8 · see citing works
Clinical Benefits and Challenges of Esketamine in Elderly Patients During the Perioperative Period
Zhang, S., Bai, C., Xu, M., Li, Y., Han, Y., Jin, Y., & Zhao, X. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s536813 · Cited by 9 · see citing works
Barbosa, M. G., Garcia, G. T., Sarin, L. M., & Jackowski, A. P. (2022) · Brazilian Journal of Psychiatry · doi:10.47626/1516-4446-2022-2876 · Cited by 9 · see citing works
Li, H., Xu, W.-J., Wang, Y., Xie, S., & Wang, H. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1476449 · Cited by 7 · see citing works
Self-citationFerreira, A. E., & Reis-Pina, P. (2024) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2024.112020 · Cited by 6 · see citing works
Liu, L., Hu, J.-H., Pan, J., Liu, H., Ji, F., & Peng, K. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s421265 · Cited by 6 · see citing works
Perspectives in treatment-resistant depression: esketamine and electroconvulsive therapy
Baldinger, P., Spies, M., Bozic, I., Kasper, S. F., Rujescu, D., & Frey, R. (2024) · Wiener klinische Wochenschrift · doi:10.1007/s00508-024-02358-w · Cited by 7 · see citing works
Gao, Z., Lu, C., Zhu, Y., Liu, Y., Lin, Y., Gao, W., Tian, L., & Wu, L. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148665 · Cited by 6 · see citing works
Hou, X., Zhang, H., Nie, Y., Zhang, Y., Wang, J., & Xu, H. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5612925 · Cited by 6 · see citing works
Self-citationWang, S., Hao, W., Fan, H., Wu, J., & Wu, L. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1663348 · Cited by 5 · see citing works
Bodnar, M. S., Barber, S., Jim, H., & Huang, J. (2024) · Journal of Anesthesia and Translational Medicine · doi:10.1016/j.jatmed.2024.10.005 · Cited by 5 · see citing works
Ketamine for postoperative avoidance of depressive symptoms: the K-PASS feasibility randomised trial
Fritz, B. A., Pennington, B. R. T., Dalton, C., Horan, C., Palanca, B. J. A., Schweiger, J. A., Griffin, L., Tumwesige, W., Willie, J. T., & Farber, N. B. (2023) · BJA Open · doi:10.1016/j.bjao.2023.100245 · Cited by 5 · see citing works
Ding, Y., Wang, Z., Huang, J., Yi, Y., & Wu, Z. (2025) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s530265 · Cited by 4 · see citing works
Shen, M., Ye, X., Chen, K., Lei, W., Huang, Y., Wang, J., Sun, J., & Lu, X. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s540781 · Cited by 4 · see citing works
Self-citationYu, K., Song, Z., Zhang, B., Pan, Q., Gan, S., Yang, S., Yang, Q.-Y., Zuo, X., & Yin, Y. (2023) · Trials · doi:10.1186/s13063-023-07575-8 · Cited by 4 · see citing works
Fei, G., Yan, W. X., & Gan, Y. (2024) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.40.8.9883 · Cited by 4 · see citing works
Pain management in cervical cancer
Rosas, S. A., Plancarte, R., Hernández-Porras, B. C., García-Andreu, J., Velazquez, B. O. L., Reyes, I., & Alarcón-Barrios, S. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1371779 · Cited by 3 · see citing works
Esketamine for postoperative sleep disturbance: clinical evidence, mechanisms, and future directions
Liu, Q., Liu, Y., Fu, Q., Gao, B., & Liu, Y. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1612230 · Cited by 6 · see citing works
Mawere-Mubvumbi, T. P. (2023) · Trends in Anaesthesia and Critical Care · doi:10.1016/j.tacc.2023.101233 · Cited by 3 · see citing works
Sun, N., Yan, W., Wang, L., Wang, J., & Wang, L. (2024) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog5102044 · Cited by 3 · see citing works
Self-citationMaekawa, R. M., Guerra, L. T. L., Bouso, J. C., Hallak, J. E. C., & SANTOS, R. G. D. (2025) · Psychoactives · doi:10.3390/psychoactives4010006 · Cited by 3 · see citing works
Use of esketamine for tracheoscopic drug injection: a randomized controlled trial
Zhao, X., Zhou, Z., Li, Z., Hu, Z., & Yu, Y. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1479741 · Cited by 4 · see citing works
Abu-Hussein, B., Elrosasy, A., Samy, H., Ali, A. S., Alijla, S. S., Bitar, A. N., & Gamal, I. (2025) · Clinical & Translational Oncology · doi:10.1007/s12094-025-03847-8 · Cited by 2 · see citing works
Sun, Q., Luo, J., Zhang, S., & Zhou, L. (2024) · Trials · doi:10.1186/s13063-024-08600-0 · Cited by 2 · see citing works
Fritz, B. A., Pennington, B. R. T., Palanca, B. J. A., Schweiger, J. A., Willie, J. T., & Farber, N. B. (2022) · F1000Research · doi:10.12688/f1000research.121529.1 · Cited by 2 · see citing works
Luo, M., Tang, N., Guo, Y., Fan, D., & Wang, X. (2025) · Actas Españolas de Psiquiatría · doi:10.62641/aep.v53i4.1965 · Cited by 1 · see citing works
Postoperative Pain Following Gynecology Oncological Surgery: A Systematic Review by Tumor Site
Chiu, S., Staley, H., Zhang, X., Mitra, A., Sorbi, F., Smith, J. R., Yazbek, J., Ghaem‐Maghami, S., Soni, S., Fotopoulou, C., et al. (2025) · Cancers · doi:10.3390/cancers17162718 · Cited by 1 · see citing works
Jing, J., Zhang, M.-Y., Yin, W., Ji, Y.-J., Sun, L., Qu, R.-Y., & Li, Y.-H. (2025) · BMC Anesthesiology · doi:10.1186/s12871-025-03570-5 · Cited by 1 · see citing works
Moriarty, S., Dushenkov, A., & Frey, K. M. (2025) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360288.2025.2607541 · Cited by 1 · see citing works
Li, J., & Wang, X. (2026) · Journal of Pain Research · doi:10.2147/jpr.s597557 · Cited by 1 · see citing works
Luo, Y., Li, J., Zhang, Y., Han, S., Rong, J., & Liu, M. (2023) · Research Square · doi:10.21203/rs.3.rs-2850500/v1 · Cited by 1 · see citing works
Hu, T., Zhang, Y., Yang, T., Liao, H., Zhou, Y., & Fu, Q. (2024) · Research Square · doi:10.21203/rs.3.rs-4010976/v1 · Cited by 1 · see citing works
ANXIETY AND DEPRESSION IN GYNECOLOGICAL CANCER
Bugaeva, M. N., & Azhymamatova, Z. T. (2022) · Научное обозрение Медицинские науки (Scientific Review Medical Sciences) · doi:10.17513/srms.1277
Breeksema, J. J. (2024) · doi:10.33612/diss.912040905
Zhang, S., Wang, L., Yang, J., Feng, X., Yang, R., & Lei, X. (2024) · Thermal Science and Engineering Progress · doi:10.1016/j.tsep.2024.103145
RetractedA Review of the Progress in Clinical Application of Esketamine
黄, 芳. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.14123165
Lu, J. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1631157
Fang, C., Hu, Z., Lv, G., Fan, X., Zhang, X., Li, W., Tian, T. I. A. N., Yuan, Y., Wang, J., & Chen, X. (2026) · Drug Design Development and Therapy · doi:10.2147/dddt.s590805
Self-citationWu, Y., Wu, H., Dong, J., Lei, L., Zhou, L., Yan, B., Chen, L., Zhou, M., Ke, P., Liu, F., et al. (2026) · Drug Design Development and Therapy · doi:10.2147/dddt.s596251
Singhal, Y., Pavan Gaurav, R., Saji, S., Pingoliya, S. K., & Ghera, D. K. (2026) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360288.2026.2679720
Zhang, B., Wang, Z., Yu, K., Pan, Q., Guan, S., Zhang, M., Jia, R., Wang, Y., Meng, Q., Ma, Y., et al. (2026) · Perioperative Medicine · doi:10.1186/s13741-026-00711-3
Self-citationChen, L., Chen, Y., Zhao, Y., Feng, T., Song, X., Xie, F., Shen, J., He, J., Guo, J., & Zhong, L. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1781915
Akwa, G., Tiemah, N. C., Chabeja, A., Buh, F. C., & Kantaris, M. (2026) · Cureus · doi:10.7759/cureus.115806
- Authors
- Wang, J., Wang, Y., Xu, X., Peng, S., Xu, F., & Liu, P.
- Affiliations
- Department of Anesthesiology, Ninth People’s Hospital of Suzhou, Suzhou, Jiangsu, China (mainland)
- Wuxi People's Hospital (CN)
- Department of Anesthesiology, Changzhou Traditional Chinese Medicine Hospital, Changzhou, Jiangsu, China (mainland)
- Shanghai University of Traditional Chinese Medicine (CN)
- Second Military Medical University (CN)
- Corresponding author
- Liu, Peirong
- Venue
- Medical Science Monitor
- Published
- 2020-04-27
- Volume
- 26
- Pages
- e922028-e922028
- ISSN
- 1234-1010 (ISSN-L)
- 1643-3750
- PMC
- PMC7331479
- OpenAlex
- W3019657248
- Cited by
- 81
- References
- 28
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 26 · 2023: 19 · 2022: 8 · 2021: 5
- FWCI
- 4.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Medical Science Monitor (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Health Sciences › Medicine › Surgery › Anesthesia and Pain Management
- Health Sciences › Medicine › Psychiatry and Mental health › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- esketamine, ketamine, depression, postoperative pain, cervical cancer, racemic ketamine, brain-derived neurotrophic factor, serotonin, dose comparison, postoperative depression
- MeSH terms
- Adult, Antidepressive Agents, Carcinoma, Uterine Cervical Neoplasms, Depression, Depressive Disorder, Double-Blind Method, Female, Humans, Hysterectomy, Ketamine, Middle Aged, Pain Measurement, Pain, Postoperative, Postoperative Pain, Serotonin, Brain-Derived Neurotrophic Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review